A randomized, double-blind, parallel-group study evaluating efficacy and safety of MEGA tablets compared to Kalcipos® tablets in adult Subjects

Registry ID
EUCTR2006-002595-17
Source registry
EUCTR
Status
Completed
Phase
PHASE3
Sponsor
Recip AB
Start date
2006-10-25
Last update
2026-08-16

Conditions

Summary

The primary objective of the study is to evaluate the efficacy of MEGA compared to Kalcipos on S-25-OH-D after 12 months treatment in Subjects aged 55-85 years with a S-25-OH-D level within 10 and 70 nmol/L at the time of screening.

Locations

View on source registry